• Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • red color

California Special Districts Association

Tuesday
May 28th
Home Education
Education Highlight

CSDA offers a full range of training programs and education seminars especially designed for special district personnel from secretary to board member. Subjects include board policy, community relations, finance, management, legal issues, and other important topics. The association is committed to keeping the cost for these high quality seminars low in order to ensure attendance by all districts - big and small.

REGISTER FOR AN EVENT

 
New Webinar: Family and Medical Care Leave Acts

Thursday, June 27, 10:00 a.m. - 12:00 p.m.

This webinar will cover the Family and Medical Leave Act (including the new 2009 regulations), the California Family Rights Act, and related family and medical leave laws. The presentation will address the conflicts and overlap of the various laws such as which employers are covered by the Acts and which employees are eligible for leave under the Acts, the reasons for which leave is permitted, how much leave time an employee is entitled to take, how the Acts overlap with pregnancy disability leave, the ADA and FEHA, whether employees are entitled to be paid while on leave and whether employees are entitled to medical insurance and other benefits while on leave. $69 CSDA Member and $99 Non-Member. Earn SDRMA Credit Incentive Points.

Register online
 
Fraud Detection/Prevention for Special Districts Webinar Next Week!

Wednesday, May 8, 10:00 a.m. - 12:00 p.m.

Financial fraud is a reality for many special districts and districts need to develop not only good internal control procedures, but a culture that says “no” to fraud and irregularities.  This webinar will talk about how to assess risk in your organization and develop policies and procedures that will mitigate risk and help prevent fraud. We will also provide resources to help you get started in looking at your organization and assessing risk.

Free to SDRMA members, $69 to CSDA members and $99 to non-member.

Earn SDRMA Credit Incentive Points

Register online
 
2013 CSDA Award Nominations Open! Due August 2

Do you have board members, staff, a chapter, or a program that you feel deserves recognition?  Now is the time to get in the spotlight!

Each year, CSDA presents various awards during the CSDA Annual Conference & Exhibitor Showcase. There are a number of different categories to enter your district and/or an individual. The following awards (by category) are open for nomination.  All nominations must be submitted by August 2, 2013.

 

Individual Awards

Board President of the Year
Nominations may be submitted for Board President of the Year based on experience, effectiveness and leadership.  Examples must be submitted that illustrate the rationale for the nomination. 

 

General Manager of the Year
Nominations will be accepted for the general manager believed to have exhibited exceptional experience, effectiveness and leadership in his or her district.  Illustrative examples must be submitted with the nomination demonstrating how the individual has excelled and brought substantial benefit to the district and/or public.

 

Staff Member of the Year Award
Selected from nominations by special district board members/trustees or district management staff. Nominations should include length of service to the district and specific accomplishments during employment.
Read more...
 
Implementing the Affordable Care Act in Your District - New Webinar!

Thursday, April 4, 10 a.m. - 12:00 p.m.

On January 1, 2014, the employer shared responsibility provisions of the federal Affordable Care Act take effect, along with penalties for large employers (50 or more full-time equivalents) who fail to meet minimum coverage standards for their employees and dependents. This webinar will provide an overview of the minimum coverage requirements, associated penalties, how to determine your “full-time” employee count with part-time and seasonal hires, and how an employer may determine whether their health care coverage is affordable.

Register online
 
More Articles...
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>

Page 1 of 7
 

Find us here also:

Facebook: Facebook Twitter: Twitter
Banner

Putting Special Districts on the Map

CSDA is proud to announce the launch of a GIS site containing location points and, in many cases, boundaries for the independent special districts in California. For more information, click here.

Banner
Banner

When administered in vitro, PDE5 inhibition induces apoptosis in colon carcinoma (15) and chronic lymphocytic leukemia cells (16). To determine whether similar effects could be observed in vivo, we used various transplantable mouse tumors, including CT26WT (a colon carcinoma; Fig. 1 A), the more aggressive variant C26GM (Fig. 1 B), TS/A (a mammary adenocarcinoma; Fig. 1 C), and the MCA203 fibrosarcoma (Fig. 1 D). PDE5 inhibitors were administered starting on the day of tumor challenge. Sildenafil and tadalafil significantly delayed tumor outgrowth by 50 to 70% in immune-competent mice, although all mice ultimately died (Fig. S1, available at http://www.jem.org/cgi/content/full/jem.20061104/DC1). Similar results were obtained even if sildenafil treatment was started on day 7 after tumor challenge in the CT26WT model (Fig. S2). The fact that no difference in tumor outgrowth was seen between early versus late administration of sildenafil suggests that PDE5 inhibition does not appreciably affect the early phases of tumor uptake but rather influences the later stages of tumor outgrowth. Because the addition of sildenafil to cultured CT26WT cells did not increase their apoptosis or affect their doubling time (unpublished data), we conclude that sildenafil does not have a direct antitumor effect but rather interferes in hosttumor interactions. Last year, the FDA's scientific advisory board criticized the agency for ignoring more than 100 academic and government studies that linked BPA with health effects. The Obama administration has pledged a "fresh look" at the issue, and the FDA is expected to complete that review by the end of this month. Figure 6. In vivo PDE5 inhibition down-regulates tumor-associated MDSC suppressive pathways. BALB/c mice were challenged with 0.5 x 106 C26GM cells and treated with sildenafil starting on day 0 or left untreated for 9 d. CD11b+ cells were obtained from the tumors and used to measure (A) intracellular cGMP and (B) IL-4R surface expression by flow cytometry. (C) Western blot analysis was performed for NOS2, ARG1, and ?-actin expression on purified tumor-associated CD11b+ cells. (D) NO production was determined as the concentration of NO3-NO2 in the supernatant, and arginase activity was determined on cell lysates and normalized for the number of cells. (E) BALB/c mice were challenged with C26GM, treated with sildenafil or the antiGr-1 depleting antibody, both treatments, or left untreated. Best fit of the data was obtained by four-parameter sigmoid curves. ANOVA p-values (PA) are reported. Error bar values are shown. MFI, multiplicity of infection. generic viagra here viagra for sale online canada looking for generic viagra? brand viagra without prescription online Dr. Gregg C. Fonarow, a professor of cardiology at the University of California, Los Angeles, noted that pulmonary hypertension is a progressive disease which results in substantial morbidity and mortality. I know where to buy viagra canadian pharmacy viagra for sale online Go with him to see the doctor. If your partner is agreeable, accompany him when he sees his doctor. This is another way to show that you're concerned and willing to work with him to treat his condition.

Sale uk viagra » Canadian Pharmacy!